Search for Clinical Trial Results

Chondrosarcoma - 22 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Proton Beam Therapy for Chondrosarcoma Condition: Chondrosarcoma Date: 2007-07-02 Interventions: Procedure: Proton Beam Therapy A total dose of up to 70 CGE given at 2.0 CGE per daily fraction for 35 f |
Recruiting |
Study Name: Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Low and Inter-mediate Grade Chondrosarcoma of the Skull Base Condition: Chondrosarcoma Date: 2010-08-12 Interventions:
|
Active, not recruiting |
Study Name: Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma Condition:
|
Suspended |
Study Name: A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas Condition: Chondrosarcoma Date: 2013-12-06 Interventions:
|
Terminated |
Study Name: A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g) Condition: Chondrosarcoma Date: 2007-10-12 Interventions: Drug: PRO95780 Intravenous repeating dose |
Completed |
Study Name: A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma Condition: Conventional Chondrosarcoma Date: 2011-03-03 Interventions:
|
Completed |
Study Name: Proton Therapy for Chordomas and/or Chondrosarcomas Condition:
Date: 2008-11-24 |
Recruiting |
Study Name: Proton Radiation for Chordomas and Chondrosarcomas Condition:
Date: 2011-10-04 Interventions: Radiation: Proton Therapy |
Recruiting |
Study Name: Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine Condition:
Date: 2007-12-28 Interventions: Radiation: Charged Particle Radiation Therapy Radiation doses will be determined by planning CT |
Active, not recruiting |
Study Name: Imatinib in Patients With Desmoid Tumor and Chondrosarcoma Condition:
Date: 2009-06-25 Interventions: Drug: Imatinib Mesylate 800 mg p.o./day (400 mg b.i.d.) for a maximum of 24 months |